This study is first to analyze the inflammatory cytokines, produced by the bronchial epithelium after exposure to areca nut extract (ANE), which contribute to airway remodeling by increasing human bronchial smooth muscle cells (BSMC) migration and proliferation. We treated human bronchial epithelial cell lines BEAS-2B and HBE135-E6E7 (HBE) with ANE, saliva-reacted ANE (sANE), and the areca alkaloids arecoline and then harvested the conditioned medium (CM) that was added to BSMC. Exposure of BEAS-2B and HBE to ANE, sANE, and arecoline increased interleukin 8 (IL-8) and Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) production. Cultures of BSMC with ANE-, sANE-, and arecoline-BEAS-2B-CM and -HBE-CM increased BSMC proliferation and migration. Induction of BSMC proliferation and migration by sANE-BEAS-2B-CM and -HBE-CM was associated with increased phosphorylation of Raf, MEK1/2, and extracellular signal regulated kinase (ERK)1/2 and the upregulation of krü ppel-like factor 5 (KLF5), cyclin D, and integrin-linked kinase. Blocking ERK1/2 by a specific inhibitor significantly decreased BSMC proliferation and migration by inhibiting KLF5 enhancement. KLF5 knockdown also decreased sANE-BEAS-2B-CM, sANE-HBE-CM, and recombinant human interleukin 8/ recombinant human RANTES-mediated BSMC proliferation and migration, suggesting that KLF5 was involved in the regulation of BSMC proliferation and migration. Our study suggests that inhibition of IL-8 and RANTES or IL-8/RANTES-mediated mitogen-activated protein kinase/KLF5 signaling is an attractive therapeutic target for areca nut-induced asthma.
The chewing of betel or areca nut is a widespread tradition in East Asia, India, and the South Pacific, and it is known to be the fourth most widely used addictive substance in the world (Gupta and Ray, 2004) . The use of areca nut has been strongly associated with the pathology of many diseases, in particular oncological disorders. The International Agency for Research on Cancer monograph declared chewing of areca nut quid to be a group 1 carcinogen, and the areca nut to be, correspondingly, a group 1 carcinogen (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004) . Investigation of saliva-reacted areca nut extract (sANE) revealed that saliva catalyzes the ingredients of areca nut into derived nitrosamines, 3-(methylnitrosamino)propionitrile, and N-nitrosoguvacoline, which are highly cytotoxic and genotoxic in human buccal epithelial cells (Chiang et al., 2007 (Chiang et al., , 2008 Lord et al., 2002; Prokopczyk et al., 1998; Sundqvist et al., 1991; Wenke et al., 1984) . Areca nut chewing has been also reported to be a pathological factor in asthma or to aggravate asthma that is already present (Kiyingi, 1991; Taylor et al., 1992) . However, the mechanisms of areca nut used, leading to increased asthma risk, are not well-understood. Asthma is a chronic respiratory tract disease characterized by airway obstruction and inflammation as well as hyperreactivity. The structural alter action of the asthmatic airway is referred to as airway remodeling (Bergeron et al., 2009 ). The major features of airway remodeling include loss of epithelial integrity, subepithelial fibrosis, goblet cell and submucosal gland enlargement, increased bronchial smooth muscle mass, and increased angiogenesis (Benayoun et al., 2003) . Human bronchial smooth muscle cells (BSMC) play a key role in the modulation of airway tone. BSMC not only increase secretory and proliferative ability but also migrate to the subepithelial area in the asthmatic airway (Benayoun et al., 2003; Dekkers et al., 2009 ). In addition, BSMC also release proinflammatory cytokines, which are responsible for the progression of asthma pathogenesis. The degree of change in bronchial smooth muscle mass has been correlated to asthma severity (Benayoun et al., 2003) .
Human krüppel-like factor 5 (KLF5) belongs to the Specificity Protein/KLF zinc finger transcription factor family, which has been reported to be involved in many cellular biologic functions, including cell cycle regulation, cell proliferation, migration, survival, and differentiation (Bialkowska FIG. 1. Continued 178 et al., 2009; Dong and Chen, 2009; He et al., 2009; Oishi et al., 2005; Yang et al., 2008) . The expression and activity of KLF5 are controlled by multiple signaling pathways, including mitogen-activated protein kinase (MAPK) and protein kinase C (Dong and Chen, 2009 ). Upregulation of KLF5 by ectopic expression or Ras activation significantly increased the rate of cell proliferation in epithelial, fibroblast, and smooth muscle cells (Dong and Chen, 2009; Nandan et al., 2008) . Overexpression of KLF5 increased keratinocyte migration via activation of integrin-linked kinase (ILK) . Although KLF5 is well-known to be related to abnormalities in cardiovascular disease-associated vascular smooth muscle cells, the role of KLF5 in BSMC has been less well-studied.
We hypothesize that areca nut may cause epithelial cells to produce inflammatory cytokines, which in turn increase the proliferation and migration of BSMC. We first assessed ANE, sANE, and the arecal alkaloid arecoline with regard to the inflammatory response in human bronchial epithelial cell lines BEAS-2B and HBE135-E6E7 (HBE). In addition, we treated BSMC with sANE-treated BEAS-2B and HBE conditioned medium (CM) and assessed the mechanism of BSMC proliferation and migration. This model provides evidence of the interaction between bronchial epithelial cells and BSMC and the mechanism of BSMC proliferation and migration after exposure to areca nut.
METHODS
Cell culture and condition medium. Two human bronchial epithelial cell lines BEAS-2B (CRL-9609) and HBE (CRL-2741) obtained from American Type Culture Collection were used in our study. BEAS-2B was cultured in bronchial epithelial growth medium (Lonza, Walkersville, MD), and HBE was maintained in keratinocyte serum-free medium with 5 ng/ml human recombinant epidermal growth factor and 0.05 mg/ml bovine pituitary extract (Invitrogen) supplemented with 0.005 mg/ml insulin and 500 ng/ml hydrocortisone. Primary human BSMC were obtained from Lonza and cultured in SmGM-2 smooth muscle medium (Lonza).
To obtain the various condition media, BEAS-2B and HBE cells (2 3 10 6 / 100-mm dish) were treated with various concentrations of ANE, sANE, and arecoline for 6 h. After treatment, the medium was replaced and the supernatants harvested after 24 h of incubation. Interleukin 8 (IL-8) and Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) depletion from various CMs was performed using anti-IL-8 or anti-RANTES antibodies (2 lg/ml, R&D System) and Sepharose A/G beads following regular immunoprecipitation techniques. Cytokine depletion was confirmed by IL-8 and RANTES ELISA assay kits.
The preparation of ANE. Areca nuts were purchased from a local commercial store and homogenized with or without a 20% human salivacontaining solution. The 20% human sANE was then incubated at 37°C for 8 h before harvesting. The aqueous ANE and sANE were immediately passed through 6-lm (Advantec) and 0.22-lm (Millipore) filters and then stored until used in a freeze-dried form at À20°C (Chiang et al., 2008) .
The ELISA. The levels of IL-8, RANTES, CXCL5, and IL-1b were determined by ELISA-based kits (R&D Systems Europe, Abingdon, UK). ELISAs were performed according to the manufacturer's instructions.
Cell proliferation. BSMC (4 3 10 3 per well) were plated in 96-well culture plates. After 24-h incubation, the cells were treated with vehicle control-CM or various condition media for 72 h. The proliferation of BSMC was determined by Premixed WST-1 Cell Proliferation Reagent (Clontech Laboratories Inc., Mountain View, CA) in accord with the manufacturer's instructions. For the blocking experiment, BSMC were pretreated with PD98059 (20lM) for 1 h and then exposed to sANE-BEAS-2B-CM, sANE-HBE-CM, and recombinant human interleukin 8 (rhIL-8)/recombinant human RANTES (rhRANTES) for an additional 72 h.
Cell migration assay. Cell migration was carried out using the QCM Chemotaxis 8-lm cell migration assay system (Millipore Corp., Bedford, MA) according to the manufacturer's instructions. Cells were seeded into the migration chamber. Control medium, various condition media, IL-8 depletion condition media, RANTES depletion conditions media, or medium containing FIG. 1. Extracts of areca nut caused an inflammatory response in human bronchial epithelial cells. The levels of IL-8 (A) and RANTES (B) in ANE-, sANE-, and arecoline-treated BEAS-2B and HBE cell lines. ANE, sANE, and arecoline did not affect the levels of IL-6 (C), CXCL5 (D), and eotaxin (E) in bronchial epithelial cells. BEAS-2B and HBE cells were treated with various concentrations of ANE, sANE, and arecoline for 6 h. The supernatants were collected, and the various cytokines level was assessed by cytokine array and ELISA kit. All experiments were performed independently at least three times. The asterisk indicates a significant difference between control and test groups, *p < 0.05. THE MECHANISM OF ARECA NUT-INDUCED ASTHMA rhIL-8 (20 ng/ml), rhRANTES (20 ng/ml), and rhIL-8 plus rhRANTES (20 þ 20 ng/ml) were placed in the lower chamber. After allowing cell migration for 24 h, cells that had migrated through the membrane were stained, lysed, and quantified on a microplate at 560 nm. For the blocking experiment, BSMC were pretreated with PD98059 (20 lM) for 1 h and then committed to migration assay.
Immunoblot/immunoprecipitation. Cells were lysed on ice for 15 min by M-PER lysis reagent (Pierce). Cell lysate was centrifuged at 14,000 3 g for 15 min and the supernatant fraction collected for immunoblot. Equivalent amounts (20 lg/ml) of protein were resolved by SDS-polyacrylamide gel electrophoresis (8-12%) and transferred to polyvinylidene fluoride membranes. After blocking for 6 h in 5% nonfat dry milk in Tris-buffered saline, the membrane was incubated with the desired primary antibody for 1-16 h. The membrane was then treated with appropriate peroxidase-conjugated secondary antibody, and the immunoreactive proteins were detected using an enhanced chemiluminescence kit (Millipore) according to the manufacturer's instructions (Hsu et al., 2010) .
Real-time reverse transcription-PCR and microarray. RNA isolation was performed using the TRIzol reagent (Invitrogen). cDNA was prepared using an oligo (dT) primer and reverse transcriptase (Takara, Shiga, Japan) following standard protocols. Real-time PCR was performed by using SYBR Green on the ABI 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA). Each PCR reaction mixture contained 200nM of each primer, 10 ll of 23 SYBR Green PCR Master Mix (Applied Biosystems), 5-ll cDNA, and RNase-free water in a total volume of 20 ll. The PCR reaction was carried out with a denaturation step at 95°C for 10 min and then for 40 cycles at 95°C for 15 s and 60°C for 1 min. All PCRs were performed in triplicate and normalized to internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Relative expression was presented using the 2
ÀnnCT method.
Microarray experiment procedures were carried out following the manufacturer's protocols. Total RNA (1 lg) was amplified by an Agilent Quick Amp Labeling Kit (Agilent Technologies). sANE-BEAS-2B-CMtreated BSMC RNA was labeled by Cy5, and control-CM-treated BSMC RNA was labeled by Cy3 in an in vitro transcription process. Cy-labeled cRNA (0.825 lg) was cleavaged to an average size of about 50-100 nucleotides by
The CM of human bronchial epithelial cells exposed to ANE, sANE, and arecoline increased proliferation and migration of BSMC. ANE-, sANE-, and arcoline-derived BEAS-2B-CM and HBE-CM increased BSMC proliferation (A) and migration (B). BEAS-2B and HBE cells (2 3 10 6 cells/100-mm dish) were treated with vehicle control and various concentrations of ANE, sANE, and arecoline for 6 h. The medium was replaced with fresh medium, and then cells were harvested after 24-h incubation. The collected medium was defined as ANE-, sANE-, or arecoline-BEAS-2B-CM and ANE-, sANE-, or arecoline-HBE-CM. The effect of ANE-, sANE-, or arecoline-BEAS-2B-CM and ANE-, sANE-, or arecoline-HBE-CM on BSMC proliferation was assessed by WST-1 after 72-h incubation. The BSMC migration was assessed by QCM Chemotaxis cell migration assay system. The asterisk indicates a significant difference between the control and test groups, as analyzed by Dunnett's test (p < 0.05). All experiments were performed independently at least three times. The asterisk indicates a significant difference between control and test groups, *p < 0.05. 180 incubation with fragmentation buffer (Agilent Technologies) at 60°C for 30 min. Equal Cy-labeled cRNA was pooled and hybridized to Agilent Whole Human Genome 4 3 44k oligo microarray (Agilent Technologies) at 65°C for 17 h. After washing and drying by nitrogen gun blowing, microarrays were scanned by an Agilent microarray scanner (Agilent Technologies) at 535 nm for Cy3 and 625 nm for Cy5. Scanned images were analyzed by Feature extraction software 10.5 (Agilent Technologies), an image analysis and normalization software was used to quantify signal and background intensity for each feature, and the data were substantially normalized by the rankconsistency-filtering locally weighted scatterplot smoothing method.
Small interfering RNA knockdown. BSMC were transfected with 1 lmol/ l nontarget or KLF5 Accell small interfering RNAs (siRNAs) pool (Dharmacon) in Accell delivery media (B-005000) according to the manufacturer's instructions. Positive controls Acell GAPDH siRNA and nontarget Accell siRNA pools were used in the experiments. After 72-h transfection, the medium was changed to whole medium, and cells were treated with cytokines or condition media. The changes of KLF5 were measured by real-time PCR, as described above.
Statistical analysis. Data were expressed as means ± SD. Statistical comparisons of the results were made using ANOVA. Significant differences (p < 0.05) between the means of the two test groups were analyzed by Dunnett's test.
RESULTS

ANEs Caused an Inflammatory Response in Human Bronchial Epithelial Cells
Increase of inflammatory response in the epithelium plays an important role in the development of asthma (Holgate et al., 2009) . We assessed the effect of two extracts of areca nut (sANE and ANE) and arecoline, on various inflammatory cytokines in human bronchial epithelial cell lines BEAS-2B and HBE. As shown in Figures 1A and 1B , ANE, sANE, and arecoline increased the production of IL-8 and RANTES in both BEAS-2B and HBE cell lines in a dose-dependent manner after 6 h of treatment. The effect of sANE is greater than that of either ANE or arecoline in IL-8 and RANTES expression. In contrast, ANE, sANE, and arecoline failed to affect the secretion of IL-6, CXCL5, and eotaxin (Figs. 1C-E) .
To ascertain that sANE-mediated effects were not due to contaminating endotoxins, sANE were treated with polymyxin B, which is known to neutralize lipopolysaccharide (LPS) activity (Hosseinzadeh et al., 2003; Lara et al., 2003) . Although IL-8 production induced by LPS was reduced by 90% in the presence of polymyxin B, no effect on IL-8 levels induced by sANE plus polymyxin B was observed. In addition, there is no difference of IL-8 production in BEAS-2B cells, which is espoused to LPS removal kit-processed and -unprocessed sANE (Supplementary figure).
The Condition Medium of ANE-, sANE-, and ArecolineTreated Epithelial Cells Increased Proliferation and Migration of BSMC Increase in BSMC mass and decreased distance between the smooth muscle and the epithelium are important features of the remodeled wall in asthmatic airways (Benayoun et al., 2003; Bergeron et al., 2009) . These changes in BSMC may be induced by many factors produced by epithelial cells (Benayoun et al., 2003; Dekkers et al., 2009) . We harvested the condition medium of BEAS-2B and HBE cells that were precultured with ANE, sANE, and arecoline for 6 h (ANE-, sANE-, arecoline-BEAS-2B-CM and ANE-, sANE-, arecoline-HBE-CM) and then assessed the effects of condition media on the proliferation and migration of BSMC. As shown in Figure 2A , all six epithelial cell condition media (ANE-, sANE-, arecoline-BEAS-2B-CM and ANE-, sANE-, arecoline-HBE-CM) increased the proliferation of BSMC in a concentration-dependent manner after 72-h treatment. Furthermore, all condition media also increased the migration of BSMC in a dose-dependent manner after a 24-h attraction (Fig. 2B ). The effect of sANE on both the induction of cell proliferation and migration is greater than that of ANE-or arecoline-treated epithelial cell-CM.
IL-8 and RANTES Are Major Factors of sANE-BEAS-2B-CM and sANE-HBE-CM in Increasing BSMC Proliferation and Migration
Because sANE appeared to have the strongest effect on epithelial cell inflammation, which can increase BSMC proliferation and migration, we selected sANE as the model to investigate the mechanism of areca nut in airway remodeling. To address the role of IL-8 and RANTES on sANE-BEAS-2B-CM-and sANE-HBE-CM-mediated BSMC proliferation and migration, we depleted IL-8, RANTES, or IL-8 plus RANTES from sANE-BEAS-2B-CM and sANE-HBE-CM. The successful depletion of IL-8 and RANTES from sANE-BEAS-2B-CM and sANE-HBE-CM was confirmed by IL-8 and RANTES ELISA kits (data not shown). As shown in Figure 3A , IL-8 or RANTES depletion only partially inhibited BSMC proliferation caused by sANE-BEAS-2B-CM and sANE-HBE-CM. In contrast, pull-down IL-8 plus RANTES completely reversed cell growth of BSMC presenting in sANE-BEAS-2B-CM and sANE-HBE-CM. Similarly, increase of BSMC migration by sANE-BEAS-2B-CM and sANE-HBE-CM was totally abrogated upon depletion of both IL-8 and
FIG. 3. IL-8 and RANTES are major factors of sANE-BEAS-2B-CM and sANE-HBE-CM in increasing BSMC proliferation and migration. (A)
The proliferation of BSMC present in IL-8 and/or RANTES depleted sANE (800 lg/ml)-BEAS-2B-CM and sANE (800 lg/ml)-HBE-CM. (B) The migration of BSMC presented in IL-8 and/or RANTES depleted sANE-BEAS-2B-CM and sANE-HBE-CM. (C) rhIL-8 and/or rhRANTES increased proliferation (C) and migration (D) in BSMC. IL-8 and RANTES depleted from sANE-BEAS-2B-CM and sANE-HBE-CM was performed using anti-IL-8 and anti-RANTES antibodies (2 lg/ml) and Sepharose A/G beads, following regular immunoprecipitation techniques. The effect of rhIL-8 (20 ng/ml), rhRANTES (20 ng/ml), rhIL-8 plus rhRANTES (20 þ 20 ng/ml), and various cytokines depleted from sANE-BEAS-2B-CM and sANE-HBE-CM on BSMC proliferation was assessed by WST-1 after 72-h incubation. BSMC migration was assessed by QCM Chemotaxis cell migration assay system. All experiments were performed independently at least three times. The asterisk indicates a significant difference between control and test groups, *p < 0.05.
FIG. 4. sANE-BEAS-2B-CM and sANE-HBE-CM increased KLF5 expression and MAPK activation. sANE-BEAS-2B-CM and rhIL-8/rhRANTES increased the expression of KLF5 assessed by microarray (A), real-time PCR (B), and immunoblot assay (C). (D) ANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES increased the levels of cyclin D and ILK. (E) sANE-BEAS-2B-CM, sANE-HBE-CM
, and rhIL-8/rhRANTES triggered the activation of MAPK cascade. BSMC was treated with sANE (800 lg/ml)-BEAS-2B-CM, sANE (800 lg/ml)-HBE-CM, and rhIL-8/rhRANTES (20 ng/ml each) for indicated times. The expression mRNA of KLF5 was assessed by microarray (6-h treatment) and real-time PCR. Phosphorylated and unphosphorylated proteins were assessed by immunoblot. The asterisk indicates a significant difference between the control and test groups, as analyzed by Dunnett's test (p < 0.05). All experiments were performed independently at least three times. (Fig. 3B) .
We also assessed the effect of rhIL-8 and rhRANTES on the proliferation and migration of BSMC. The results showed that both rhIL-8 and rhRANTES increase BSMC proliferation. Furthermore, the combination of rhIL-8 and rhRANTES caused a synergistic enhancement of BSMC proliferation (Fig. 3C) . Similarly, both rhIL-8 and rhRANTES increased the BSMC migration ability, and this effect was further enhanced when rhIL-8 was combined with rhRANTES to act as chemotaxis agent for BSMC (Fig. 3D) .
sANE-BEAS-2B-CM and sANE-HBE-CM Increased the Activation of KLF5 and MAPK
We assessed all changes in gene expression in sANE-BEAS-2B-CM-and rhIL-8/rhRANTES-treated BSMC by microarrays. The 2-fold gene expressions are listed in Supplementary table 1. The results showed that the expression of KLF5 increased in both sANE-BEAS-2B-CM-and rhIL-8/rhRANTES-treated BSMC (Fig. 4A) . Real-time PCR and immunoblot assay also further confirmed the upregulation effect of sANE-BEAS-2B-CM and rhIL-8/rhRANTES in mRNA and protein levels in BSMC (Figs. 4B and 4C ). Because KLF5 has been found to regulate transcriptions of cell cycle-related protein cyclin D and cell migration-controlled ILK, we also analyzed the expression of cyclin D and ILK. Figure 4D shows that sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES increased the expression of cyclin D and ILK in BSMC.
MAPK signaling is postulated to integrate growth factor, cytokine, and integrin signals and to be involved in the regulation of KLF5, which in turn modulates cell proliferation and migration (Mori et al., 2009; Yao et al., 2008) . We assessed whether sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/ rhRANTES induce BSMC proliferation and migration by MAPK cascade. The results showed that sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES increased the phosphorylation of Raf, MEK1/2, and extracellular signal regulated kinase (ERK)1/2 in BSMC, but did not cause any change in the protein levels of total proteins (Fig. 4E) .
Involvement of KLF5 in BSMC Proliferation and Migration
Induced by sANE-Treated Epithelial Cells
We next used specific siRNA to investigate the role of KLF5 on BSMC proliferation and migration induced by sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES. As shown in Figure 5A , in comparison with the control, KLF5 siRNA reduced KLF5 expression approximately 70%. Inhibition of KLF5 by siRNA decreased the upregulation of cyclin D and ILK induced by sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES (Fig. 5B) . Selective genetic inhibition of KLF5 abrogated BSMC proliferation induced by sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES (Fig. 5C ). In addition, KLF5 inhibition also decreased sANE-BEAS-2B-CM-, sANE-HBE-CM-, and rhIL-8/rhRANTES-mediated cell migration in BSMC (Fig. 5D) . These results suggest that KLF5 may play a key role in areca nut-mediated BSMC proliferation and migration.
The Role of MAPK on BSMC Proliferation and Migration
Induced by sANE-Treated Epithelial Cells To understand whether the expression of KLF5 is regulated by MAPK, we pretreated BSMC with PD98059 (MEK1/2, an upstream kinase of ERK1/2, inhibitor), then exposed the cells to sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/ rhRANTES. The effect of ERK inhibitors on the expression of KLF5, cell migration, and proliferation was then examined. It was found that pretreatment of BSMC with ERK inhibitors reduced phosphorylation of ERK induced by sANE-BEAS-2B-CM, sANE-HBE-CM, or rhIL-8/rhRANTES (Fig. 6A) . Also, specific inhibitor of ERK abrogated KLF5 upregulation in BSMC after sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES treatment (Fig. 6A) . The increase of cell proliferation was also abrogated in BSMC after sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES treatment (Fig. 6B) . Furthermore, ERK inhibition decreased sANE-BEAS-2B-CM-, sANE-HBE-CM-, and rhIL-8/rhRANTES-mediated enhancement of BSMC migration (Fig. 6C) .
sANE-BEAS-2B-CM Increased the Expression of
Inflammatory and Chemotaxis Factors in BSMC Increased inflammatory response of BSMC is a key pathological feature in the development of airway remodeling (Dekkers et al., 2009) . We consequently investigated whether ANE enhanced the inflammation through interaction of the epithelium and BSMC and found that sANE-BEAS-2B-CM increased the transcription of various inflammatory cytokines, including CXCL2, CXCL5, CXCL6, IL-1b, and IL-8, as determined by microarray (Fig. 7A) . These findings were further verified by real-time PCR (Fig. 7B ) in sANE-BEAS-2B-CM-treated BSMC. In addition, sANE-BEAS-2B-CM increased the amounts of CXCL5, IL-1b, and IL-8 on the protein levels (Figs. 7C-E) .
DISCUSSION
The present study is the first to investigate the interaction of airway epithelium and smooth muscle after exposure to ANE. indicated times (6 h for KLF5, 12 h for cyclin D and ILK, 72 h for proliferation, and 24 h for cell migration assay). The level of KLF5 mRNA was assessed by RT-PCR after 72-h transfection. Cell proliferation was assessed by WST-1 and BSMC migration was assessed by QCM Chemotaxis cell migration assay system. All experiments were performed independently at least three times. The asterisk indicates a significant difference between control and test groups, *p < 0.05. expression and ERK1/2 phosphorylation. ERK inhibitor reduced BSMC proliferation (B) and migration (C) induced by sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES. BSMC were pretreated with PD98059 (20lM) for 1 h and then exposed to sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES (45 min for ERK phosphorylation and 6 h for KLF5 expression, 72 h for proliferation assay, and 24 h for migration assay). The asterisk indicates a significant difference between the control and test groups, as analyzed by Dunnett's test (p < 0.05). All experiments were performed independently at least three times. 186 ANE, sANE, and arecoline caused human bronchial epithelial cell lines BEAS-2B and HBE to secrete IL-8 and RANTES, which enhance the proliferation and migration of human BSMCs. In addition, sANE-derived human epithelial cell condition medium, or a combination of IL-8 with RANTES, increased ERL1/2 activation, subsequently increasing KLF5 expression in BSMC. Consequently, blocking the upstream molecule ERK or downstream factor KLF5 upregulation reverses their induction effect on BSMC proliferation and migration. These data suggest that ERK1/2 and KLF5 play important roles in areca nut-mediated asthma.
Airway inflammation is a major factor in the pathogenesis of asthma (Benayoun et al., 2003; Dekkers et al., 2009 ). The bronchial epithelium is known to play a critical regulatory role in the maintenance of airway function and integrity (Davies, 2009; Makinde et al., 2007) . Bronchial epithelium can produce various factors and cytokines/chemokines to regulate other systems or tissues, including BSMC (Benayoun et al., 2003; Bossé et al., 2008) . Our results show that two extracts of areca nut: water extract and saliva-containing extract, together with areca nut compound arecoline, caused epithelial cells to produce inflammatory cytokines IL-8 and RANTES, which subsequently induced BSMC proliferation and migration. Depleteing both IL-8 and RANTES completely reversed the effect of sANE-BEAS-2B-CM-and sANE-HBE-CM-mediated BSMC proliferation and migration, suggesting this effect is a synergistic influence of IL-8 and RANTES. However, removal of either IL-8 or RANTES alone did not completely block the effect of sANE-derived human epithelial cell condition medium on BSMC migration and proliferation. This is an important correlation to our finding on the clinical significance of elevated IL-8 and RANTES levels in asthma patients.
sANE exhibited the strongest effect on the induction of inflammation response in epithelial cells, which in turn displayed the greatest stimulatory effect on BSMC proliferation and migration. The formation of nitrosamines derivatives, nitrosamines, 3-(methylnitrosamino)propionitrile, and Nnitrosoguvacoline from areca nut alkaloids produced by saliva in the oral cavity has been suggested as constituting the primary cause of oral mucosal lesions (Chiang et al., 2007 (Chiang et al., , 2008 Lord et al., 2002; Prokopczyk et al., 1998; Sundqvist et al., 1991; Wenke et al., 1984) . In our study, the effect of sANE on the induction of inflammatory response was greater than that of ANE. Therefore, the reactions of areca nut to saliva not only enhance its carcinogenicity but also increase the pathogenicity of asthma.
KLF5, a zinc finger-containing transcription factor, exhibits a regulatory role on many cellular biological progresses, such as cell proliferation, apoptosis, migration, and differentiation (Dong and Chen, 2009; Suzuki et al., 2009) . Recent studies have shown that angiotensin II increased KLF 5 expression, enhancing the proliferation of vascular smooth muscle cells by cyclin D upregulation and p21 repression (Liu et al., 2010) . Lack of KLF5 inhibited maturation of the lungs at the saccular stage of lung development, and abnormalities of the lung were observed in several structures, including the bronchial smooth muscle (Wan et al., 2008) . However, the effect of endogenous KLF5 on BSMCs remains largely unknown. In this study, we have shown that treatment of BSMC with sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES resulted in increased KLF5 expression at both transcriptional and translation levels, whereas inhibition of ERK1/2 decreased the upregulation of KLF5 by sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES, suggesting that ERK1/2 is the upstream event of KLF5. Knockdown of KLF5 by siRNA decreased cyclin D and BSMC proliferation induced by sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES, suggesting that cooperation of KLF5/cyclin D is associated with cell proliferation. Moreover, KLF5 siRNA also reduced the effects of sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES on ILK upregulation and migration in BSMC, suggesting that KLF5 also plays a crucial role in areca nut-mediated cell migration. The regulatory role of KLF5 on BSMC proliferation and migration plays a critical new role for KLF5 involved in airway remodeling.
Several studies have demonstrated the necessary role. ERK1/ 2 plays in the regulation of BSMC growth and migration (Duan and Wong, 2006) , and many studies have reported that activation of ERK1/2 increases smooth muscle cell growth and migration, whereas both chemical inhibitors and ERK1/2 siRNA transfection decreased the proliferation and migration of BSMC (Gerthoffer and Singer, 2003; Pera et al., 2010) . In our study, we found that sANE-BEAS-2B-CM, sANE-HBE-CM, and rhIL-8/rhRANTES increased the phosphorylation of Raf, MEK1/2, and ERK1/2. However, selective inhibition of ERK1/2 by chemical inhibitors decreased the effects of sANE-BEAS-2B-CM, sANE-HBE-CM. or rhIL-8/rhRANTES on BSMC proliferation and migration, suggesting that the cooperation of Raf/MEK1/2/ERK1/2 cascade plays a crucial FIG. 7 . sANE-BEAS-2B-CM and sANE-HBE-CM increased the expression of inflammatory and chemotaxis factors in BSMC. sANE (800 lg/ml)-BEAS-2B-CM and sANE (800 lg/ml)-HBE-CM increased the expression of inflammatory factors and chemotaxis in mRNA levels, assessed by microarray (A) and real-time PCR (B). sANE (800 lg/ml)-BEAS-2B-CM and sANE (800 lg/ml)-HBE-CM also increased the amounts of CXCL5 (C), IL-1b (D), and IL-8 (E) on protein levels. BSMC were treated with sANE-BEAS-2B-CM and sANE-HBE-CM for 6 h, and the mRNA expressions was assessed by microarray and real-time PCR. For (C) to (E), BSMC were treated with sANE-BEAS-2B and sANE-HBE-CM for indicated times, and the amounts of the various proteins detected by ELISA kit. All experiments were performed independently at least three times. The asterisk indicates a significant difference between control and test groups, *p < 0.05.
